You Li

3.3k total citations · 1 hit paper
79 papers, 2.4k citations indexed

About

You Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, You Li has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 22 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in You Li's work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (10 papers) and Circular RNAs in diseases (5 papers). You Li is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (10 papers) and Circular RNAs in diseases (5 papers). You Li collaborates with scholars based in China, United States and Australia. You Li's co-authors include Meijuan Zhao, Kāri Stefánsson, Timothy Vartanian, Qinghua Wu, Wenda Wu, Eugenie Nepovimová, Kamil Kuča, Zbyněk Heger, Vojtěch Adam and Chuan‐Ming Hao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

You Li

73 papers receiving 2.3k citations

Hit Papers

Hypoxia-inducible factors: master regulators of hypoxic t... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
You Li China 23 1.1k 729 369 350 313 79 2.4k
Jian Zhu China 31 1.2k 1.1× 407 0.6× 326 0.9× 422 1.2× 289 0.9× 96 2.5k
Jing Hao China 25 1.3k 1.2× 491 0.7× 293 0.8× 141 0.4× 202 0.6× 116 2.3k
Hamid Rezvani France 27 1.1k 1.0× 427 0.6× 273 0.7× 119 0.3× 252 0.8× 106 2.2k
Weiliang Xia China 32 1.4k 1.3× 486 0.7× 407 1.1× 117 0.3× 217 0.7× 103 2.8k
Yoshinori Otsuki Japan 34 1.6k 1.5× 492 0.7× 368 1.0× 173 0.5× 360 1.2× 110 3.0k
Hongwei Zhang China 23 1.3k 1.2× 408 0.6× 335 0.9× 191 0.5× 257 0.8× 93 1.9k
Wei Tan China 30 1.1k 1.0× 551 0.8× 376 1.0× 105 0.3× 483 1.5× 94 2.2k
Ting Wan China 29 795 0.7× 287 0.4× 340 0.9× 135 0.4× 511 1.6× 108 2.2k
Prasanna Krishnamurthy United States 32 1.9k 1.7× 616 0.8× 206 0.6× 180 0.5× 464 1.5× 74 3.1k

Countries citing papers authored by You Li

Since Specialization
Citations

This map shows the geographic impact of You Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You Li more than expected).

Fields of papers citing papers by You Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by You Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You Li. The network helps show where You Li may publish in the future.

Co-authorship network of co-authors of You Li

This figure shows the co-authorship network connecting the top 25 collaborators of You Li. A scholar is included among the top collaborators of You Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with You Li. You Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, You, Liming Xu, Guangming Yang, et al.. (2025). SQSTM1/p62 Mediates the Effects of CPNE3 on the Epithelialmesenchymal Transition and Migration Inhibition of Lung Adenocarcinoma Cells. Current Medicinal Chemistry. 32(40). 9212–9223.
2.
Zhang, Meihui, Yingqi Li, You Li, et al.. (2024). Gut microbiota dysbiosis-mediated ceramides elevation contributes to corticosterone-induced depression by impairing mitochondrial function. npj Biofilms and Microbiomes. 10(1). 111–111. 8 indexed citations
3.
Yu, Zhengtao, Jiameng Li, You Li, et al.. (2023). [miRNA-128-3p inhibits malignant behavior of glioma cells by downregulating KLHDC8A expression].. PubMed. 43(9). 1447–1459.
4.
Li, You, et al.. (2023). Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report. Translational Lung Cancer Research. 12(3). 629–636. 7 indexed citations
6.
Wu, Qinghua, You Li, Eugenie Nepovimová, et al.. (2022). Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. Journal of Hematology & Oncology. 15(1). 77–77. 292 indexed citations breakdown →
7.
Li, You, Yifan Wei, He Li, et al.. (2022). Exogenous Parathyroid Hormone Alleviates Intervertebral Disc Degeneration through the Sonic Hedgehog Signalling Pathway Mediated by CREB. Oxidative Medicine and Cellular Longevity. 2022(1). 9955677–9955677. 12 indexed citations
8.
Li, You, et al.. (2022). OIP5-AS1 Inhibits Oxidative Stress and Inflammation in Ischemic Stroke Through miR-155-5p/IRF2BP2 Axis. Neurochemical Research. 48(5). 1382–1394. 8 indexed citations
9.
Li, You, Jingyi Xue, Shuang Chen, et al.. (2022). LncRNA PVT1 is a novel mediator promoting the angiogenesis response associated with collateral artery formation. The International Journal of Biochemistry & Cell Biology. 151. 106294–106294. 8 indexed citations
10.
Cao, Jing, Yuehua Zhang, Xiaojin Guo, et al.. (2021). Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis. Annals of Translational Medicine. 9(8). 705–705. 8 indexed citations
11.
Li, Xinchun, et al.. (2020). Strategies for enrichment of circulating tumor cells. Translational Cancer Research. 9(3). 2012–2025. 41 indexed citations
13.
Yuan, Ling‐Qing, Zhenlin Zhang, Weibo Xia, et al.. (2018). Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment. Medicine. 97(31). e11694–e11694. 8 indexed citations
14.
Li, You, Feng Yang, & Deliang Fu. (2018). Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas. World Journal of Gastrointestinal Oncology. 10(7). 184–193. 27 indexed citations
15.
Damerla, Rama Rao, Cheng Cui, George C. Gabriel, et al.. (2015). Novel Jbts17 mutant mouse model of Joubert syndrome with cilia transition zone defects and cerebellar and other ciliopathy related anomalies. Human Molecular Genetics. 24(14). 3994–4005. 33 indexed citations
16.
He, Wenjuan, Yingying Wang, Ming‐Zhi Zhang, et al.. (2010). Sirt1 activation protects the mouse renal medulla from oxidative injury. Journal of Clinical Investigation. 120(4). 1056–1068. 275 indexed citations
17.
Zhang, Minmin, Jing Chen, Lingyun Lai, et al.. (2009). Aldosterone Promotes Fibronectin Synthesis in Rat Mesangial Cells via ERK1/2-Stimulated Na<sup>+</sup>-H<sup>+</sup> Exchanger Isoform 1. American Journal of Nephrology. 31(1). 75–82. 15 indexed citations
18.
Zhang, Minmin, Jing Chen, Shaojun Liu, et al.. (2009). The Role of Na+-H+Exchanger Isoform 1 in Aldosterone-Induced Glomerulosclerosis in Vivo. Renal Failure. 31(8). 726–735. 7 indexed citations
19.
Cai, Ji-Ping, Rui-Li Wei, Xiaoye Ma, Huang Zhu, & You Li. (2001). Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro. International Ophthalmology. 24(4). 225–231. 10 indexed citations
20.
Guo, Ailin, Wei Lei, Shi H, Li X, & You Li. (2000). [Matrix metalloproteinase-1 and coronary atheroslerotic plaque rupture].. PubMed. 29(4). 263–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026